Recall record at a glance
| Official record | F-0504-2015 |
|---|---|
| Category | Food Recalls |
| Classification | Class II |
| FDA record status | Terminated |
| Recalling firm | Original Soup Man |
| Report date | Nov 26, 2014 |
| Recall initiation date | Sep 24, 2014 |
| Quantity | Total of 3,083 cases (1859 cases/12/17 oz and 1244 cases/6/17 oz) |
| Location | Staten Island, NY, United States |
Official product description
THE ORIGINAL SOUPMAN Lobster Bisque, Net Wt 17 oz (482 g). Product is packed as a tetra pak and ships as a pack of 12 or 6 containers per carton. Distributed exclusively by: SoupMan Inc. Staten Island, NY 10314
Why the product was recalled
The Original Soup Man has recalled Lobster Bisque due to the presense of Undeclared Shrimp, Tilapia and Perch.
Distribution information
retail stores nationwide
How to read the classification
FDA Class II indicates a situation in which use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote. The classification shown here comes from the FDA record.
Additional record details
Recall type: Voluntary: Firm initiated. Initial notification: Press Release.
What to do next
If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.
About this record
Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.
FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.